Your browser doesn't support javascript.
loading
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men.
Aubé, Eliana; Lewin, Antoine; O'Brien, Sheila F; Grégoire, Yves; Pillonel, Josiane; Steele, Whitney R; Custer, Brian; Davison, Katy L; Germain, Marc; Seed, Clive R; Camirand Lemyre, Félix.
Afiliação
  • Aubé E; Department of Mathematics, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Lewin A; Medical Affairs and Innovation, Héma-Québec, Montreal, Quebec, Canada.
  • O'Brien SF; Medical Affairs and Innovation, Héma-Québec, Montreal, Quebec, Canada.
  • Grégoire Y; Faculty of Medicine and Health Science, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Pillonel J; Epidemiology & Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
  • Steele WR; Medical Affairs and Innovation, Héma-Québec, Quebec City, Quebec, Canada.
  • Custer B; Direction des Maladies Infectieuses, Santé Publique France, St. Maurice, France.
  • Davison KL; Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
  • Germain M; Epidemiology and Health Policy Science, Vitalant Research Institute, San Francisco, California, USA.
  • Seed CR; Department of Laboratory Medicine, UCSF, San Francisco, California, USA.
  • Camirand Lemyre F; Immunisation, Hepatitis & Blood Safety, Health Protection Agency, London, UK.
Vox Sang ; 117(2): 201-207, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34268781
ABSTRACT
BACKGROUND AND

OBJECTIVES:

In Canada, men having sex with men (MSM) are deferred for 3 months from last sexual contact to reduce human immunodeficiency virus (HIV) risk to recipients. The aim of this paper was to model the Canadian residual risk of HIV-positive source plasma incorporating pathogen inactivation (PI) under no MSM deferral scenarios for apheresis plasma donations. MATERIALS AND

METHODS:

A combined Bayesian network (BN) and Monte Carlo approach were implemented to estimate the HIV residual risk under 3-month deferral compared with no deferral without quarantine scenarios for MSM donors. Models involve the stochastic generation of donation and its infection status based on its corresponding simulated donor profile. Viral load reduction conferred by PI used by source plasma fractionators was simulated. Model parameters were derived from Héma-Québec and Canadian Blood Services data, viral loads in a large sample of HIV-positive US blood donors, CSL Behring documentation and from published data.

RESULTS:

In the most likely scenario for the 3-month deferral model, there were 2.71 positive donations per 1,000,000 donations (95% confidence interval [CI] 2.63-2.78). For the no-deferral model, there were 3.01 positive donations per 1,000,000 donations (95% CI 2.94-3.09). For both scenarios, the risk of having an infectious pool was 0 in 300,000 pools (95% CI 0-0.0000123) after consideration of PI.

CONCLUSION:

Based on simulation results, there would be a negligible HIV residual risk associated with the removal of a time-based MSM deferral without quarantine for source plasma incorporating PI.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Remoção de Componentes Sanguíneos / Infecções por HIV / Minorias Sexuais e de Gênero Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Vox Sang Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Remoção de Componentes Sanguíneos / Infecções por HIV / Minorias Sexuais e de Gênero Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Vox Sang Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá